ArticleOptometry and vision science : official publication of the American Academy of Optometry2025
Comparing visual acuity and optimized visual image quality for individuals with and without Down syndrome.
Article in Optometry and vision science : official publication of the American Academy of Optometry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
significanceIndividuals with Down syndrome experience reduced visual image quality compared with individuals without Down syndrome, even when wearing spectacle prescriptions that have been optimized to maximize visual image quality. PURPOSE: Individuals with Down syndrome are known to have reduced visual acuity; however, it is unknown whether their visual image quality is proportionately reduced. The purpose of this study was to evaluate optimized image quality via visual Strehl ratio (VSX), a measure of visual image quality known to be correlated with visual acuity, in a group of individuals with Down syndrome, and compare the optimized logVSX values to those predicted from a cohort of individuals without Down syndrome.
methodsWavefront aberration measures were recorded on 30 adults with Down syndrome (age = 29 ± 10 years). A computer program was used to mathematically apply more than 20,000 sphero-cylindrical refractions to the uncorrected wavefront error of each eye. The residual wavefront error was then used to calculate optimized logVSX for each eye. These optimized logVSX values were compared with predicted age and pupil-matched normal levels of optimized logVSX. The logMAR visual acuity measured from individuals with Down syndrome wearing optimized corrections was compared with normative values in the literature for the typical population.
resultsOptimized logVSX values were significantly poorer for individuals with Down syndrome (average: -0.56 ± 0.19) compared with the minimum (average: -0.47 ± 0.12) or mean (average: -0.26 ± 0.10) values predicted in the typical population. Visual acuity in this group of individuals with Down syndrome was also reduced compared with normative values, and there was a significant relationship between visual acuity and optimized logVSX (p=0.03), though with a modest correlation, suggesting that other factors likely also contribute to reduced visual acuity.
conclusionsIndividuals with Down syndrome have reduced logVSX values compared with individuals without Down syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.